ROLE OF Pirfenidone in COVID 19?
Pirfenidone (5-methyl-1-phenyl-2-[1H]-pyridone), is a novel anti-fibrotic agent with trivial adverse effects. Pirfenidone is approved for the treatment of Idiopathic Pulmonary Fibrosis (IPF) for patients with mild to moderate disease. Pirfenidone could inhibit apoptosis, downregulate ACE receptors expression, decrease inflammation by several mechanisms and ameliorate oxidative stress and hence protect pneumocytes and other cells from COVID-19 invasion and cytokine storm simultaneously. Based on the pirfenidone mechanism of action and the known pathophysiology of COVID-19, I believe that pirfenidone has the potential for the treatment of COVID-19 patients.
Pirfenidone.. used for pulmonary fibrosis treatment... But must be considered after 2 months ...
AS IT.. INHIBIT .. APOPTOSIS.. IT PROTECTS.. PNEUMOCYTES AND OTHER CELLS.. FROM COVID-19..INVASION..
Definitely use in cases of Pulmonary fibrosis Routine use any chest physician can opion
Cases that would interest you
- Login to View the image
30 yrs female with severe dyspnoea and cough. Diagnose
Dr. Ramesh Dutt Gautam2 Likes15 Answers - Login to View the image
29/male having cough since 2 months not subsiding with antibiotics; interpret
Dr. Isha Garg4 Likes15 Answers - Login to View the image
69 years having tiredness breathlessness cough 6 month no history of fever htn , dm ecg wnl
Dr. Allu Rao4 Likes18 Answers - Login to View the image
A 47 yo male presented with malaise, cough, and a low-grade fever over several weeks. He was found to have serum oxygen saturation of 88% on room air. Laboratory evaluation was notable for leukopenia to 2.5. Frontal chest radiograph & CT images is attached. Help please.
Dr. Monali Chugh1 Like15 Answers - Login to View the image
36 year male coal mine worker came to opd with chief complaint of hemoptysis, low grade fever, decreased apetite since last 24 days. diagnosis and management?
Dr. Niket Mantri1 Like17 Answers